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The authors contend that organized psychology's efforts to gain limited 
prescriptive privileges may be misguided. The modification of psychology's 
traditional scope of practice may produce harm in the form of lessened patient 
regard, devaluation of nonpharmacologic elements of practice, and markedly 
increased exposure to claims of malpractice. The authors also decry the 
disingenuous use of psychopharmacologically "underserved" populations as 
rationales for the pursuit of prescriptive privileges. Psychology may mount a 
major effort to make this change without sufficient justification, in the view 
of the authors. 
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WHAT H A S H A P P E N E D ?  
In our previous lives as graduate students and interns, we recall being 
exhorted to avoid the "medical model" in dealing with our patients. Maher 
(1966) even states, "Thus, the more usual physician-patient relationship of 
physical medicine is often inappropriate for the task of changing deviant 
behavior and may even mitigate against it" (p. 30). In particular, we recall 
being taught to not regard behavioral deviations as diseases which represent 
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"pathology" which may respond to "therapies." From a more pithy per- 
spective, we were cautioned that we should not emulate "pill pushers," who 
provide some symptomatic relief without effectively changing the behavior 
of our clients for the better or significantly improving their lives. 
Now a number of psychologists (upwards of 60% as described in vari- 
ous surveys) are interested in providing training to psychologists such that 
they could prescribe psychoactive medications and advocate a "national 
agenda" to this end (DeLeon, Fox, & Graham, 1991). We are somewhat 
troubled by this seeming turnaround in the perspective of the medical 
model and the "therapy" of psychological "patients" with a treatment mo- 
dality which psychologists previously regarded as alien. 
As a personal observation, we can say that many psychologists' minds 
are not completely made up about this issue. They remain open to this 
notion of prescription privileges and would be willing not only to be per- 
suaded that it is of value, but to invest some considerable personal effort 
in learning to do it if necessary. The trouble is that it is not clear at this 
time that the privilege of prescribing medications is viable or valuable for 
psychology. We ground this sort of current perception in our over 20 years 
of experience in various medical settings extending back to graduate school. 
We have worked in medical/surgical, psychiatric, rehabilitation, and geriat- 
ric settings. In all of these environments, teaching and research have played 
a role, and we have been privileged to work with colleagues in various 
branches in medicine whose prescribing behaviors run the gamut of what 
is going on in the medical world. One of us (K.M.A.) also enjoyed a faculty 
appointment stint at a university medical center in Ontario, Canada, and 
has some first-hand observations about how life really is in that delivery 
system as well, as it is often held out as a model of how our public health 
delivery system should work with respect to medicine. 
Our general impression is that as one gets closer and closer to the 
nature of medicines and prescribing, the appeal as the primary care mo- 
dality with respect to mental health becomes less and less. This is a trend 
that seems to replicate in our own informal surveying. Like many things, 
the more you know about it, the more you see the strengths and weak- 
nesses. We see that in the evolving debate on prescription privileges, the 
most vocal proponents are often those with the least experience in positions 
that would give them first-hand chances to see the successes and miscues 
that current prescribers experience. Psychologists who have worked in clinic 
settings have also observed that quite often the psychiatrist on the team 
resents being forced into a role of pharmaceutical vending machine. We 
have had psychiatric colleagues bemoan the fact that they really do not 
feel as if they are practicing medicine anymore and, certainly, feel that 
their psychotherapeutic skills are atrophied from disuse. 
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THE NATURE OF PRESCRIBING 
There are a number of reasons for our general impression concerning 
psychologists and prescription privileges and we would like to offer them 
for your consideration. 
First, to prescribe well in a sense of quality of care is a difficult en- 
terprise. We happen to think that psychiatry is an extraordinarily 
worthwhile medical career choice and one whose promise is very challeng- 
ing for the trainee to realize. Making the best of biological psychiatry in 
terms of effecting behavior change is a very difficult intellectual goal. As 
a result of this difficult target and other influences in educating people to 
deliver psychiatric services, we would say that the skill level of practice is 
not at all what it could or should be in the psychiatric community at large. 
We may be biased in that we are privileged to work with psychiatric col- 
leagues who are master clinicians and "cutting-edge" researchers in the 
area of psychopharmacology. Even for those doing very good work in this 
regard, there is a knowledge base that is shifting and changing at a rate 
that would challenge anyone to keep up. 
In response to intimations that psychologists might be interested in 
this kind of work, a number of reports and guidelines have been published 
suggesting what a "model" prescribing curriculum might be for psycholo- 
gists to be able to engage in this activity. One particularly good one is the 
American College of Neuropsychopharmacology (ACNP) report (Glick, 
Janowsky, Salzman, & Shader, 1990). These kinds of guidelines are largely 
good sets of standards and could very profitably be used actually to evaluate 
and improve the training and skills of those currently engaging in prescrib- 
ing behavior now--much less in an enhanced or expanded provider panel. 
We would hazard to guess that a substantial number of licensed practitio- 
ners in psychiatry might not be able to demonstrate the competencies 
suggested in these model standards. 
Another closer concern for us in considering the substrate question 
is the lack of fully satisfactory information concerning the mechanism and 
sites of action of the drugs most likely to be used. While there has been 
clear progress in psychopharmacology for the past three or four decades, 
the general role of psychopharmacology is as of yet still a palliative and 
symptom control one. Psychopharmacology is not curative and is unlikely 
to be so for the immediate future. This is rather a different situation than 
for other prescribing areas such as infectious disease, for example, where 
dispensing often has a more curative purpose. This state of affairs does 
not exist because pharmaceutical companies and organized psychopharma- 
cology are indolent and dull. Those of us in the psychological profession 
who know something about neurochemistry and behavior realize how hard 
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it is to design effective agents. This issue needs to be kept prominently in 
mind in considering what one might want or might not want to do in terms 
of acquiring new care modalities. Of course, it goes without saying that the 
psychoactive drugs which psychologists are interested primarily in prescrib- 
ing have wide ranging effects  on and in teract ions  with mult iple  
physiological systems. For example, let us consider a commonly prescribed 
antidepressant, Norpramin. How many psychologists are genuinely con- 
ce rned  with this drug ' s  po ten t i a l  for  in t e rac t ion  with a lcohol ,  
sedative-hypnotics, or other CNS depressants? How many will take regular 
blood tests to check for the changes in glucose that this medication can 
produce? How many psychologists know what glucose is? There is far more 
to prescribing than symptom amelioration. 
With respect to the current level of care and people's access to it, it 
would be hard to characterize as acceptable the ways in which older pa- 
tients in particular are treated with drugs from a general practice or 
psychiatric perspective. However, pointing fingers at medicine or psychiatry 
would not really be fair, since treatment of the elderly, the sick, the in- 
fected, or the defective is our society's collective shame these days. We are 
afraid that we have failed to see the magnitude of our mental health needs 
as a society in context, and shedding what appear to be crocodile tears 
about the mentally ill without access to care or coverage has become some- 
what of a national sport in televised hearings on C-Span and legislative 
assemblies around the country. We are not the only profession trying to 
use the disadvantaged to advantage, and we draw no comfort from the fact 
that organized psychiatry on the national level sometimes looks even more 
pretentious than psychology in playing at being socially conscious and po- 
litically correct. 
Our questions about health care delivery with respect to psychophar- 
macology in the elderly would also extend to a query about the range of 
psychopharmacological agents which are actually appropriate and effica- 
cious in the geriatric patient. We frankly do not see much being done in 
psychopharmacology for seniors beyond "air strike" potency treatment for 
disruptive patients and crop-dusting for sleep disorders being done in nurs- 
ing home care environments. Where are the marvelous tools that are going 
to enable us to deal in a curative fashion with things such as Alzheimer's 
disease at this time? What sorts of education will enable psychologists to 
use, deftly, agents such as tricyclic antidepressants which have such complex 
effects and cardiovascular risks? 
Quality of care with respect to psychopharmacology is not what it 
should be generally in psychiatry and medicine. This is not news to these 
professions and we doubt strongly that much is accomplished by pointing 
this out with an arrogant subliminal message that we psychologists could 
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do it better (or at least as well). We are quite certain that the quality of 
psychopharmacological care in certain public institutions such as state hos- 
pitals and nursing homes is liable to be lower than in independent practice 
or private institutions. There is occasionally a simple calculus of personnel, 
with off-brand medical qualifications and dubious--if any--residencies 
making a shaky foundation for psychopharmacological practice in too many 
institutions. We are willing to allow that patients deserve better, but we 
guess that we are just not ready to volunteer our profession as being in- 
trinsically better at this element of care. We will also allow that in some 
centers it would be hard to be worse. 
There is another aspect of the push for prescription privileges that is 
a bit touchy because it is just plain economic in scope. Why are we as a 
profession so eager to get into public-sector prescribing when the economics 
are so dismal? Are we not trying to reserve a deck chair on the Titanic in 
this respect? Many psychiatric colleagues we know and respect are having 
a devil of a time finding ways to treat publicly financed and now even private 
insurance patients. Reimbursement is absolutely dismal and the states and 
insurers collectively have decided to play a game of fiscal chicken with 
healthcare institutions and providers, simply dumping professional and eco- 
nomic responsibility into their laps unbidden. Costs are claimed to be the 
culprit, but we do not see providers being better off economically in pro- 
portion to the "increased costs." Be these things as they may, any observer 
of outpatient and especially inpatient settings featuring psychopharmacology 
will also see the tremendously increasing acuity and insistence that stays and 
density of care be continuously reduced. Anyone seriously trying to provide 
quality assessment and/or treatment to patients at the rates compensated 
by Medicaid will predictably cut corners in services, refuse to treat, or even 
in the case of a few misguided individuals, simply cheat. 
The force fields of economics are changing in other respects to that 
relevant for prescription privilege for psychologists. Managed care is be- 
coming the norm in services in general, and certainly mental health is 
getting its full share of finished models being put in place--ready or not. 
The managed care mode of service delivery for mental health promises to 
build on trends that have already been evolving in recent mental health 
reimbursement. Inpatient days are likely to become even harder to justify 
and stays even shorter in duration. It is no longer feasible in the reim- 
bursement environment now evolving to really try to create a therapeutic 
milieu or logically take a patient through a hospitalization designed to deal 
correctly or comprehensively with the problems that resulted in admission. 
Bluntly, psychotherapy is disappearing in our inpatient units. Rather, where 
inpatient care is justified, it will be simply to weather the worst of the storm 
and return the patient to the community no longer in a state of complete 
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collapse. The key to even hoping to do this successfully is continuity of 
care, but there is not sufficient discussion of this concept in most managed 
care models being implemented. Another clear trend is likely to be use of 
urgent or emergent care facilities to try to weather the worst of the storm 
and return the patient to the custody of the family--if they have one--with 
some fantasied hope that they will pursue outpatient treatment. 
On the emergency treatment front, psychopharmacology would have 
an obvious appeal in terms of more immediate control of patient violence 
or disorganization, but we frankly do not see psychologists or psychiatrists 
lining up to do this sort of work. It is necessary, but dirty and hard. The 
emergency room may be a glamorous place for television dramas, but in 
real life there are few takers for this type of posting in most health systems, 
public or private. Staff or faculty who do good work in such settings are 
extraordinarily valuable. 
POLITICALLY CORRECT MOTIVATIONS 
Another oft-used reason for psychologists to be in the business of 
prescribing has to do with underserved populations and the problems of 
access. We hope that we as a profession do not really mean to come into 
hearing rooms in state capitals or Washington with a straight face and try 
to sway lawmakers that it is our major intent and fondest wish to treat the 
poor, the disadvantaged, people of color, or others who seemingly get less 
than their due of mental health resources. We doubt, for example, that 
upon enactment of this prescription privilege legislation, we will see bus 
loads of psychologists leaving to set up new practices in Wounded Knee, 
South Dakota, the South Bronx, or the Cass Corridor in Detroit. It is prob- 
ably reasonable not to be totally cynical about every interest group that 
appears backing legislation favorable to it; but the public and its repre- 
sentatives are likely to be more than a bit cautious in listening to us 
describe societal needs that just happen to be financially remunerative. 
The corollary with respect to poor standards of practice in psycho- 
pharmacology by currently licensed groups has to do with how we would 
behave as providers of these services. Is there any reason to think that the 
variability among psychologists in terms of the use of psychoactive drugs 
would be any different from that of currently licensed providers? There 
are some providers who are relatively heavy prescribers, while others may 
use medicine selectively or not at all in some cases. This variability gives 
rise to yet another source of public concern regarding psychoactive drugs. 
At the present time, many individuals needing mental health services select 
psychologists precisely because the psychologist does not utilize psycho- 
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pharmacology (whether or not it is a wise decision). People are increasingly 
skeptical of things that they put in their body in the form of food or drugs, 
and introducing the prescription privilege would add a new source of con- 
cern for patients in terms of their evaluation of providers. This would 
become even more confusing in the instance that we create a subdivision 
of the profession based on those who had the prescription privilege and 
those who did not. At this particular point, we will not focus on the liability 
problem as it is so obvious as to be not worthy of much comment. Our 
exposure and malpractice premiums will increase manyfold. We will never 
really be in the malpractice insurance stratosphere, but we would go from 
a presently modest coverage to a new order of risk. There are likely to be 
limits on malpractice and tort settlements more generally introduced in so- 
ciety, but we really must expect that if we are going to treat all of the 
needy persons that we claim we are, there will be some small proportion 
of mistakes and those injured thereby will want to have their day in court. 
PRESCRIBING AS A SIMPLE COMPETENCY 
Perhaps the most compelling thing that we need to consider at this 
• point is the impact of the argument that "prescribing is a simple compe- 
tency" that is a matter of training by brief course or workshop. We happen 
to think that this is nonsense if one really is interested in quality of care 
in psychopharmacology. Regardless of whether one thinks this is true or 
not in relationship to psychopharmacology, it really means that we should 
expect the same argument introduced to us with respect to other services 
that we currently provide, including things such as psychological testing and 
treatment. If a psychologist can take a brief course and learn how to pre- 
scribe, why cannot an occupational therapist do the same thing with respect 
to psychological testing and be fully capable of setting up a MMPI evalu- 
ation service? 
We imagine that for many of our friends who might want prescription 
privileges, there would be no shortage of huffing and puffing about the 
kind of development and incursion into psychological practice described 
just above. Many psychologists are justifiably angry when psychiatrists with 
no training in measurement or psychological testing start their own testing 
shops with no training, but a computer printout mill. Arming psychologists 
with prescription pads after being blessed as 6-week wonders strikes us as 
equally objectionable. The bottom line is this--How would we reasonably 
take a position to oppose incursions into our own profession if we simply 
claim that every professional skill in our portfolio is a simple competency 
that can be earned like Cub Scout merit badges? Or do we go to a more 
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intermediate model involving what is done in martial arts? Could one have 
a green belt in family therapy, a black belt in psychological testing, or a 
brown belt in psychopharmacology? 
Humor aside, ff we do decide to take this "no big deal" position re- 
garding psychopharmacology, we can expect the same logical argument 
turned on us. We personally have a lot of problems with the "simple com- 
petency" model, although we are thoroughly in favor of evaluating, 
certifying, and recertifying professional competencies such as they now ex- 
ist. If we are serious about keeping current and keeping professional misfits 
off the licensure street, this is the way to go. We think that the public, 
however, will simply demand that professions be done with a very solid 
pedagogic base and not simply left to vagaries of competing claims in a 
particular area. The legislative public is already sick and tired of psychology 
and psychiatry coming to hearing rooms at each other's throats. They have 
no skills to understand who may be "right" or "wrong" about the particular 
instant issue, but they are likely to act in a way that will leave at least one 
party--and perhaps both--disappointed. It strikes us as unwise profession- 
ally, unsound scientifically, and ruinous politically to continue to proceed 
in our bumptious ways with respect to early cheerleading for a jihad with 
the American Psychiatric Association or even the American Medical As- 
sociation on the prescription issue. One would think that we as organized 
psychologists do not have enough to do in cleaning and improving our own 
clinical, educational, and research houses when in fact the proliferation of 
low-level training programs is threatening to deflate that respect which our 
profession has fought so hard to acquire. 
We would urge caution, consideration, and consultation on this issue. 
If there are problems unique to the delivery system for mental health care, 
say, in the Federal Indian Health Service or remote military installations, 
these problems could be compassionately considered and solved without 
using the underserved as a pretext for a theoretically naive and practically 
self-destructive campaign. We have yet to hear a cogent case to proceed 
with creating prescription privilege legislation, and the dominant focus in 
statements and papers written by proponents is on the nature of current 
legislation granting prescribing rights. These legislatively adept individuals 
point out that the laws could indeed be changed to include a psychologist's 
prescription privileges without bringing down the temple of organized 
health care. This focus misses the whole point. Of course laws could be 
changed. We could press for legislation making us certified public account- 
ants, jumbo jet pilots, neurosurgeons, or professional sports agents. The 
entire question is whether laws should be changed to provide psychologists 
prescription privileges under certain conditions. We are as yet unpersuaded 
on this particular issue and feel that our mentors may have been correct 
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in urging us to behave as psychologists and behavioral scientists, not the 
purveyors of balms and potions. 
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